The History of Early Breast Cancer Treatment

被引：52
作者：
Ben-Dror, Judith [1 ]
Shalamov, Michal [2 ]
Sonnenblick, Amir [1 ,2 ]
机构：
[1] Tel Aviv Sourasky Med Ctr, IL-6423906 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-6997801 Tel Aviv, Israel
来源：
GENES | 2022年 / 13卷 / 06期
关键词：
breast cancer; molecular therapeutics; systemic treatment; targeted therapies; SURGICAL ADJUVANT BREAST; SENTINEL-NODE BIOPSY; NEOADJUVANT CHEMOTHERAPY; ENDOCRINE THERAPY; INTERNAL MAMMARY; RANDOMIZED-TRIAL; FOLLOW-UP; PREOPERATIVE CHEMOTHERAPY; AXILLARY DISSECTION; CONSERVING THERAPY;
D O I：
10.3390/genes13060960
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
"The story of cancer is the story of human ingenuity, resilience, and perseverance, but also of hubris, paternalism, and misperception" (Siddhartha Mukherjee). The present review discusses the evolution of early breast cancer (BC) treatment philosophy in the last 50 years and the shift from an emphasis on local therapy to an emphasis on systemic precision treatment options.
引用
收藏
页数：12
相关论文
共 78 条
  • [1] Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
  • [2] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials
    Albain, K.
    Anderson, S.
    Arriagada, R.
    Barlow, W.
    Bergh, J.
    Bliss, J.
    Buyse, M.
    Cameron, D.
    Carrasco, E.
    Clarke, M.
    Correa, C.
    Coates, A.
    Collins, R.
    Costantino, J.
    Cutter, D.
    Cuzick, J.
    Darby, S.
    Davidson, N.
    Davies, C.
    Davies, K.
    Delmestri, A.
    Di Leo, A.
    Dowsett, M.
    Elphinstone, P.
    Evans, V.
    Ewertz, M.
    Gelber, R.
    Gettins, L.
    Geyer, C.
    Goldhirsch, A.
    Godwin, J.
    Gray, R.
    Gregory, C.
    Hayes, D.
    Hill, C.
    Ingle, J.
    Jakesz, R.
    James, S.
    Kaufmann, M.
    Kerr, A.
    MacKinnon, E.
    McGale, P.
    McHugh, T.
    Norton, L.
    Ohashi, Y.
    Paik, S.
    Pan, H. C.
    Perez, E.
    Peto, R.
    Piccart, M.
    [J]. LANCET, 2012, 379 (9814) : 432 - 444
  • [3] Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer
    Andre, Fabrice
    Ciruelos, Eva
    Rubovszky, Gabor
    Campone, Mario
    Loibl, Sibylle
    Rugo, Hope S.
    Iwata, Hiroji
    Conte, Pierfranco
    Mayer, Ingrid A.
    Kaufman, Bella
    Yamashita, Toshinari
    Lu, Yen-Shen
    Inoue, Kenichi
    Takahashi, Masato
    Papai, Zsuzsanna
    Longin, Anne-Sophie
    Mills, David
    Wilke, Celine
    Hirawat, Samit
    Juric, Dejan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (20) : 1929 - 1940
  • [4] [Anonymous], USE LETROZOLE AROMAT
  • [5] [Anonymous], 2013, J CLIN ONCOL, V31, P5, DOI [10.1200/jco.2013.31.18suppl.5, 10.1200/jco.2013.31.18_suppl.5]
  • [6] Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study
    Bachelot, Thomas
    Bourgier, Celine
    Cropet, Claire
    Ray-Coquard, Isabelle
    Ferrero, Jean-Marc
    Freyer, Gilles
    Abadie-Lacourtoisie, Sophie
    Eymard, Jean-Christophe
    Debled, Marc
    Spaeth, Dominique
    Legouffe, Eric
    Allouache, Djelila
    El Kouri, Claude
    Pujade-Lauraine, Eric
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (22) : 2718 - 2724
  • [7] Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
    Bardia, A.
    Hurvitz, S. A.
    Tolaney, S. M.
    Loirat, D.
    Punie, K.
    Oliveira, M.
    Brufsky, A.
    Sardesai, S. D.
    Kalinsky, K.
    Zelnak, A. B.
    Weaver, R.
    Traina, T.
    Dalenc, F.
    Aftimos, P.
    Lynce, F.
    Diab, S.
    Cortes, J.
    O'Shaughnessy, J.
    Dieras, V
    Ferrario, C.
    Schmid, P.
    Carey, L. A.
    Gianni, L.
    Piccart, M. J.
    Loibl, S.
    Goldenberg, D. M.
    Hong, Q.
    Olivo, M. S.
    Itri, L. M.
    Rugo, H. S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16) : 1529 - 1541
  • [8] Efficacy and Safety of Anti-Trop-2 Antibody Drug Conjugate Sacituzumab Govitecan (IMMU-132) in Heavily Pretreated Patients With Metastatic Triple-Negative Breast Cancer
    Bardia, Aditya
    Mayer, Ingrid A.
    Diamond, Jennifer R.
    Moroose, Rebecca L.
    Isakoff, Steven J.
    Starodub, Alexander N.
    Shah, Nikita C.
    O'Shaughnessy, Joyce
    Kalinsky, Kevin
    Guarino, Michael
    Abramson, Vandana
    Juric, Dejan
    Tolaney, Sara M.
    Berlin, Jordan
    Messersmith, Wells A.
    Ocean, Allyson J.
    Wegener, William A.
    Maliakal, Pius
    Sharkey, Robert M.
    Govindan, Serengulam V.
    Goldenberg, David M.
    Vahdat, Linda T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) : 2141 - +
  • [9] Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer
    Blum, JL
    Jones, SE
    Buzdar, AU
    LoRusso, PM
    Kuter, I
    Vogel, C
    Osterwalder, B
    Burger, HU
    Brown, CS
    Griffin, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 485 - 493
  • [10] COMBINATION CHEMOTHERAPY AS AN ADJUVANT TREATMENT IN OPERABLE BREAST-CANCER
    BONADONNA, G
    BRUSAMOLINO, E
    VALAGUSSA, P
    ROSSI, A
    BRUGNATELLI, L
    BRAMBILLA, C
    DELENA, M
    TANCINI, G
    BAJETTA, E
    MUSUMECI, R
    VERONESI, U
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1976, 294 (08) : 405 - 410
12345678